FEV1 helps measure the progression of lung conditions such as chronic obstructive pulmonary disease (COPD) or asthma. FEV stands for forced expiratory volume, which is the air you exhale in one ...

Individuals with COPD have an increased risk of mortality from exposure to extreme temperatures, both heat and cold, as well as from exposure to air pollution. Climate change is affecting the health ...

Ohtuvayre (ensifentrine), a drug approved in 2024 to treat chronic obstructive pulmonary disorder (COPD), is receiving high marks from doctors and patients. Ohtuvayre is the first new inhaled COPD ...

Among older adults with established ASCVD, hospitalization for COPD increases risk of ASCVD hospitalization. The risk for atherosclerotic cardiovascular disease (ASCVD) hospitalization after ...

Verona Pharma has blockbuster hopes for its recently approved drug for chronic obstructive pulmonary disorder (COPD), and preliminary sales figures for the drug suggest it is heading in the right ...

Compared with DPP-4 inhibitors, SGLT2 inhibitors and GLP-1RAs conferred lower risks for COPD exacerbation among patients with type 2 diabetes. Among patients with type 2 diabetes (T2D) and active ...

People with COPD and CVD vs CVD alone were less likely to receive preventive cardiac care such as medications, cardiologist referrals, and coronary bypass graft surgery. Patients with chronic ...

Verona Pharma has claimed FDA approval for its chronic obstructive pulmonary disease (COPD) drug ensifentrine, which has been tipped as a future blockbuster. The first-in-class dual ...

Background The natural history and time course of the onset of exacerbation events of chronic obstructive pulmonary disease (COPD) is incompletely understood. Methods A prospective cohort of 212 ...

Traditional inhaler therapies continue to play a key role in disease management. Credit: NMK-Studio / Shutterstock. The chronic obstructive pulmonary disease (COPD) market across the seven major ...